Home Page

PIONEERING

CELL & ANTIBODY-BASED

CANCER THERAPEUTICS

NEWS


'Alphageneron Announces Successful Completion of Pre-IND Meeting for ENKASTIMâ„¢ NK Cell Therapy with the US FDA on September 27 2021'

Harvard Square, One Mifflin Place, Suite 400

Cambridge, MA 02138, USA